Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice

Manabu Nakazono; Shigeo Hasegawa; Tsuneyuki Yamamoto; Kiyoshi Zaitsu

doi:10.1016/j.bmcl.2004.08.053

Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice

Manabu Nakazono, Shigeo Hasegawa, Tsuneyuki Yamamoto, Kiyoshi Zaitsu

Molecular Bioinformatics

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

The 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene was synthesized from N,N′-di(1-adamantyl)malondiamide and C ₆₀ in the presence of 1,8-diazabicyclo[5,4,0]-7-undecene. The intraperitoneal administration of this fullerene derivative (10 mg/kg) caused an antagonistic effect on haloperidol-induced catalepsy in mice.

Original language	English
Pages (from-to)	5619-5621
Number of pages	3
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	14
Issue number	22
DOIs	https://doi.org/10.1016/j.bmcl.2004.08.053
Publication status	Published - Nov 15 2004

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmcl.2004.08.053

Fingerprint Dive into the research topics of 'Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice'. Together they form a unique fingerprint.

Cite this

Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice. / Nakazono, Manabu; Hasegawa, Shigeo; Yamamoto, Tsuneyuki; Zaitsu, Kiyoshi.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 14, No. 22, 15.11.2004, p. 5619-5621.

Research output: Contribution to journal › Article › peer-review

@article{477d4d88ba834e998446ada1d7c049fe,

title = "Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice",

abstract = "The 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene was synthesized from N,N′-di(1-adamantyl)malondiamide and C 60 in the presence of 1,8-diazabicyclo[5,4,0]-7-undecene. The intraperitoneal administration of this fullerene derivative (10 mg/kg) caused an antagonistic effect on haloperidol-induced catalepsy in mice.",

author = "Manabu Nakazono and Shigeo Hasegawa and Tsuneyuki Yamamoto and Kiyoshi Zaitsu",

year = "2004",

month = nov,

day = "15",

doi = "10.1016/j.bmcl.2004.08.053",

language = "English",

volume = "14",

pages = "5619--5621",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "22",

}

TY - JOUR

T1 - Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice

AU - Nakazono, Manabu

AU - Hasegawa, Shigeo

AU - Yamamoto, Tsuneyuki

AU - Zaitsu, Kiyoshi

PY - 2004/11/15

Y1 - 2004/11/15

N2 - The 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene was synthesized from N,N′-di(1-adamantyl)malondiamide and C 60 in the presence of 1,8-diazabicyclo[5,4,0]-7-undecene. The intraperitoneal administration of this fullerene derivative (10 mg/kg) caused an antagonistic effect on haloperidol-induced catalepsy in mice.

AB - The 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene was synthesized from N,N′-di(1-adamantyl)malondiamide and C 60 in the presence of 1,8-diazabicyclo[5,4,0]-7-undecene. The intraperitoneal administration of this fullerene derivative (10 mg/kg) caused an antagonistic effect on haloperidol-induced catalepsy in mice.

UR - http://www.scopus.com/inward/record.url?scp=5144229405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5144229405&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2004.08.053

DO - 10.1016/j.bmcl.2004.08.053

M3 - Article

C2 - 15482935

AN - SCOPUS:5144229405

VL - 14

SP - 5619

EP - 5621

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 22

ER -